EVANS, ET AL v. BAYER HEALTHCARE PHARMACEUTICALS, INC., ET AL
| CARLETON EVANS and LISA EVANS |
| TEVA PHARMACEUTICALS USA INC., BARR LABORATORIES, INC., BAYER SCHERING PHARMA AG and BAYER HEALTHCARE PHARMACEUTICALS INC. |
| 1:2018cv03892 |
| December 11, 2018 |
| US District Court for the Southern District of Indiana |
| Tim A Baker |
| Mark J Dinsmore |
| Tanya Walton Pratt |
| Personal Inj. Prod. Liability |
| 28 U.S.C. § 1332 |
| Both |
Docket Report
RSS Track this Docket
This docket was last retrieved on December 11, 2018. A more recent docket listing may be available from PACER.
| Document Text |
|---|
| Filing 65 MAGISTRATE JUDGE's NOTICE of Availability to Exercise Jurisdiction issued. (NAD) |
| Filing 64 Case transferred in from District of Illinois Southern; Case Number 3:10-cv-11481. Original file copy of transfer order and docket sheet received. |
Filing 63
ORDER TRANSFERRING CASE TO OTHER DISTRICT pursuant to 28 U.S.C. Section 1404(a): Case transferred to United States District Court for the Southern District of Indiana. The Clerk of Court is DIRECTED to transmit the complete file in this case to the Clerk of the United States District Court for the Southern District of Indiana. Signed by Judge David R. Herndon on 12/7/2018. (Attachments: #1 Joint Remand and Transfer Memorandum)(ceh) [Transferred from Illinois Southern on 12/11/2018.]
|
| Filing 62 Memorandum to Transferee Court from Transferor Court containing case-specific details to help aid in transfer. (ceh) [Transferred from Illinois Southern on 12/11/2018.] |
| Filing 61 REPLY to Response to Motion re #30 MOTION to Exclude - Bayer's Daubert Motion to Exclude Dr. Wojciech Mazur's Expert Opinions Barr/Teva's Joinder in Bayers Response to Plaintiffs Supplemental Response to Defendants Motion to Exclude the Testimony of Dr. Wojciech Mazur filed by Barr Laboratories, Inc., Teva Pharmaceuticals USA, Inc.. (Suffern, Michael) [Transferred from Illinois Southern on 12/11/2018.] |
| Filing 60 REPLY to Response to Motion re #33 MOTION for Summary Judgment , #27 MOTION for Summary Judgment Barr/Teva's Response to Plaintiffs' Supplemental Response in Opposition to Defendants' Motion for Summary Judgment filed by Barr Laboratories, Inc., Teva Pharmaceuticals USA, Inc.. (Suffern, Michael) [Transferred from Illinois Southern on 12/11/2018.] |
| Filing 59 REPLY to Response to Motion re #30 MOTION to Exclude - Bayer's Daubert Motion to Exclude Dr. Wojciech Mazur's Expert Opinions - Bayer's and Barr/Teva's Response to Plaintiffs' Supplemental Response to Defendants' Motion to Exclude Dr. Wojciech Mazur's Expert Opinions filed by Barr Laboratories, Inc., Bayer Healthcare Pharmaceuticals, Inc., Bayer Schering Pharma AG, Teva Pharmaceuticals USA, Inc.. (Attachments: #1 Exhibit 16 - Salem 2018 Article, #2 Exhibit 17 - Solomon Supplemental Report, #3 Exhibit 18 - Mazur Deposition Excerpts, #4 Exhibit 19 - Mazur Addendum, #5 Exhibit 20 - FDA Webpage)(Lueckenhoff, Terry) [Transferred from Illinois Southern on 12/11/2018.] |
| Filing 58 REPLY to Response to Motion re #33 MOTION for Summary Judgment , #27 MOTION for Summary Judgment - Bayer's and Barr/Teva's Response to Plaintiffs' Supplemental Response in Opposition to Defendants' Motion for Summary Judgment filed by Barr Laboratories, Inc., Bayer Healthcare Pharmaceuticals, Inc., Bayer Schering Pharma AG, Teva Pharmaceuticals USA, Inc.. (Attachments: #1 Exhibit 26 - Salem 2018 Article, #2 Exhibit 27 - Salem 2017 Article, #3 Exhibit 28 - Mazur Deposition Excerpts, #4 Exhibit 29 - Mazur Addendum, #5 Exhibit 30 - Solomon Supplemental Report)(Lueckenhoff, Terry) [Transferred from Illinois Southern on 12/11/2018.] |
|
Filing 57
CASE MANAGEMENT ORDER NO. 85 - Order Disbanding the Plaintiffs' Steering Committee. Signed by Judge David R. Herndon on 11/20/2018. (arf) [Transferred from Illinois Southern on 12/11/2018.]
|
| Filing 56 RESPONSE in Opposition re #33 MOTION for Summary Judgment , #27 MOTION for Summary Judgment Plaintiffs' Supplemental Response in Opposition to Defendants' Motion for Summary Judgment filed by Carleton Evans, Lisa Evans. (Attachments: #1 Exhibit 1 Salem 2018, #2 Exhibit 2 Mazur Addendum)(Abaray, Janet) [Transferred from Illinois Southern on 12/11/2018.] |
| Filing 55 RESPONSE in Opposition re #30 MOTION to Exclude - Bayer's Daubert Motion to Exclude Dr. Wojciech Mazur's Expert Opinions Plaintiffs' Supplemental Response in Opposition to Defendants' Motion to Exclude Dr. Wojciech Mazur's Expert Opinions filed by Carleton Evans, Lisa Evans. (Attachments: #1 Exhibit 1 Salem 2018, #2 Exhibit 2 Mazur Addendum, #3 Exhibit 3 Sedlak 2013, #4 Exhibit 4 11.7.18 Mazur Dep Tr, #5 Exhibit 5 Solomon Supp Report, #6 Exhibit 6 E14 Guidance For Industry, #7 Exhibit 7 6.16.17 Mazur Dep Tr Excerpts)(Abaray, Janet) [Transferred from Illinois Southern on 12/11/2018.] |
|
Filing 54
ORDER granting #53 Motion for Order to Amend CMO 83 Deadlines. See Order for details. Signed by Judge David R. Herndon on 10/29/2018. (ceh) [Transferred from Illinois Southern on 12/11/2018.]
|
| Filing 53 MOTION for Order to Joint Motion to Modify CM0 83 Deadlines by Carleton Evans, Lisa Evans. (Abaray, Janet) [Transferred from Illinois Southern on 12/11/2018.] |
|
Filing 52
ORDER granting #51 Motion for Order to Amend CMO 83 Deadlines. See Order establishing new deadlines concerning supplemental reports/motions. Signed by Judge David R. Herndon on 9/19/2018. (ceh) [Transferred from Illinois Southern on 12/11/2018.]
|
| Filing 51 MOTION for Order to - Defendants' Motion to Modify CMO 83 Deadlines by Barr Laboratories, Inc., Bayer Healthcare Pharmaceuticals, Inc., Bayer Schering Pharma AG, Teva Pharmaceuticals USA, Inc.. (Lueckenhoff, Terry) [Transferred from Illinois Southern on 12/11/2018.] |
|
Filing 50
ORDER granting #48 Plaintiffs' Motion for Leave to Supplement Their Opposition to (1) Defendants' Motions to Exclude the Expert Opinion of Dr. Wojciech Mazur; and (2) Defendants' Motions for Summary Judgment. Pursuant to SDIL Local Rule 7.1(c), the Court finds that the supplemental expert report of Dr. Mazur is appropriately submitted based on a change in facts after the filing of the parties' briefs. Defendants' opposition falls to the weight and credibility of the expert and does not necessitate the need to prevent the supplemental report. Accordingly, plaintiffs are permitted to supplement the record with Dr. Mazur's supplemental report describing a topical August 2018 study. To the extent defendants request the relief laid out in the conclusion of their #49 opposition, the Court directs defendants to file a motion offering an appropriate scheduling order by 9/18/2018. Signed by Judge David R. Herndon on 9/6/2018. (ceh)THIS TEXT ENTRY IS AN ORDER OF THE COURT. NO FURTHER DOCUMENTATION WILL BE MAILED. [Transferred from Illinois Southern on 12/11/2018.]
|
| Filing 49 SEALED RESPONSE to Motion re #48 MOTION for Leave to File Plaintiffs' Motion For Leave to Supplement Their Opposition to (1)Defendants' Motions to Exclude the Expert Opinion of Dr. Wojciech Mazur and (2) Defendants' Motions For Summary Judgment filed by Barr Laboratories, Inc., Bayer Healthcare Pharmaceuticals, Inc., Bayer Schering Pharma AG, Teva Pharmaceuticals USA, Inc.. (Lueckenhoff, Terry) [Transferred from Illinois Southern on 12/11/2018.] |
| Filing 48 MOTION for Leave to File Plaintiffs' Motion For Leave to Supplement Their Opposition to (1)Defendants' Motions to Exclude the Expert Opinion of Dr. Wojciech Mazur and (2) Defendants' Motions For Summary Judgment by Carleton Evans, Lisa Evans. (Attachments: #1 Exhibit A - Dr. Mazur August 2018 Report, #2 Exhibit B - Salem 2018 Study)(Abaray, Janet) [Transferred from Illinois Southern on 12/11/2018.] |
| Filing 47 REPLY to Response to Motion re #33 MOTION for Summary Judgment - Defendants' Reply in Further Support of Its Motion for Summary Judgment filed by Barr Laboratories, Inc., Teva Pharmaceuticals USA, Inc.. (Suffern, Michael) [Transferred from Illinois Southern on 12/11/2018.] |
| Filing 46 REPLY to Response to Motion re #27 MOTION for Summary Judgment - Bayer's Reply Memoradum in Support of Its Motion for Summary Judgment filed by Bayer Healthcare Pharmaceuticals, Inc., Bayer Schering Pharma AG. (Lueckenhoff, Terry) [Transferred from Illinois Southern on 12/11/2018.] |
| Filing 45 Sealed Document. (Attachments: #1 Exhibit 2, #2 Exhibit 3, #3 Exhibit 4, #4 Exhibit 5, #5 Exhibit 6, #6 Exhibit 7, #7 Exhibit 8, #8 Exhibit 9)(Tregre, Calvin) [Transferred from Illinois Southern on 12/11/2018.] |
| Filing 44 RESPONSE in Opposition re #33 MOTION for Summary Judgment , #27 MOTION for Summary Judgment Plaintiffs' Response in Opposition to Defendants' Motion for Summary Judgment filed by Carleton Evans, Lisa Evans. (Attachments: #1 Exhibit 1 - Filed Under Seal, #2 Exhibit 2 - Filed Under Seal, #3 Exhibit 3 - Filed Under Seal, #4 Exhibit 4 - Filed Under Seal, #5 Exhibit 5 - Filed Under Seal, #6 Exhibit 6 - Filed Under Seal, #7 Exhibit 7 - Filed Under Seal, #8 Exhibit 8 - Filed Under Seal, #9 Exhibit 9 - Filed Under Seal)(Tregre, Calvin) [Transferred from Illinois Southern on 12/11/2018.] |
| Filing 43 Sealed Document. (Attachments: #1 Exhibit 2, #2 Exhibit 3, #3 Exhibit 4, #4 Exhibit 5, #5 Exhibit 6, #6 Exhibit 7, #7 Exhibit 8, #8 Exhibit 9, #9 Exhibit 10)(Tregre, Calvin) [Transferred from Illinois Southern on 12/11/2018.] |
| Filing 42 RESPONSE in Opposition re #30 MOTION to Exclude - Bayer's Daubert Motion to Exclude Dr. Wojciech Mazur's Expert Opinions Plaintiffs' Response In Opposition To Defendants' Motion To Exclude Dr. Wojciech Mazur's Expert Opinions filed by Carleton Evans, Lisa Evans. (Attachments: #1 Exhibit 1 - Filed Under Seal, #2 Exhibit 2 - Filed Under Seal, #3 Exhibit 3 - Filed Under Seal, #4 Exhibit 4 - Filed Under Seal, #5 Exhibit 5 - Filed Under Seal, #6 Exhibit 6 - Filed Under Seal, #7 Exhibit 7 - Filed Under Seal, #8 Exhibit 8 - Filed Under Seal, #9 Exhibit 9 - Filed Under Seal, #10 Exhibit 10 - Filed Under Seal)(Tregre, Calvin) [Transferred from Illinois Southern on 12/11/2018.] |
|
Filing 41
ORDER granting #40 Unopposed Motion to Modify CMO 83 deadlines. Plaintiffs have up to and including January 26, 2018 to file their responses to pending dispositive and Daubert motions. Signed by Judge David R. Herndon on 1/22/2018. (ceh)THIS TEXT ENTRY IS AN ORDER OF THE COURT. NO FURTHER DOCUMENTATION WILL BE MAILED. [Transferred from Illinois Southern on 12/11/2018.]
|
| Filing 40 MOTION to Amend/Correct 26 Order on Motion for Order, Unopposed Motion to Modify CMO 83 Deadlines by Carleton Evans, Lisa Evans. (Tregre, Calvin) [Transferred from Illinois Southern on 12/11/2018.] |
|
Filing 39
ORDER granting #38 Motion to Amend/Correct. Plaintiffs' responses to dispositive and Daubert motions due on or before January 22, 2018. Signed by Judge David R. Herndon on 1/12/2018. (ceh)THIS TEXT ENTRY IS AN ORDER OF THE COURT. NO FURTHER DOCUMENTATION WILL BE MAILED. [Transferred from Illinois Southern on 12/11/2018.]
|
| Filing 38 MOTION to Amend/Correct 26 Order on Motion for Order, Unopposed Motion to Modify CMO 83 Deadlines by Carleton Evans, Lisa Evans. (Tregre, Calvin) [Transferred from Illinois Southern on 12/11/2018.] |
| Filing 37 JOINDER by Barr Laboratories, Inc., Teva Pharmaceuticals USA, Inc.. Joinder in #30 MOTION to Exclude - Bayer's Daubert Motion to Exclude Dr. Wojciech Mazur's Expert Opinions, #31 Memorandum in Support of Motion,,, . (Suffern, Michael) [Transferred from Illinois Southern on 12/11/2018.] |
| Filing 36 Sealed Document. (Attachments: #1 Exhibit E - Sealed, #2 Exhibit F- Sealed)(Suffern, Michael) [Transferred from Illinois Southern on 12/11/2018.] |
| Filing 35 AFFIDAVIT re #33 MOTION for Summary Judgment , #34 Memorandum in Support of Motion by Barr Laboratories, Inc., Teva Pharmaceuticals USA, Inc.. (Attachments: #1 Exhibit A -Gannon Order 4/24/14, #2 Exhibit B -Gannon Order 11/18/15, #3 Exhibit C -DelRosario Excerpts, #4 Exhibit D -Evans Excerpts, #5 Exhibit E -Sealed, #6 Exhibit F - Sealed)(Suffern, Michael) [Transferred from Illinois Southern on 12/11/2018.] |
| Filing 34 MEMORANDUM in Support re #33 MOTION for Summary Judgment filed by Barr Laboratories, Inc., Teva Pharmaceuticals USA, Inc.. (Suffern, Michael) [Transferred from Illinois Southern on 12/11/2018.] |
| Filing 33 MOTION for Summary Judgment by Barr Laboratories, Inc., Teva Pharmaceuticals USA, Inc.. Responses due by 1/19/2018 (Suffern, Michael) [Transferred from Illinois Southern on 12/11/2018.] |
| Filing 32 Sealed Document. (Lueckenhoff, Terry) [Transferred from Illinois Southern on 12/11/2018.] |
| Filing 31 MEMORANDUM in Support re #30 MOTION to Exclude - Bayer's Daubert Motion to Exclude Dr. Wojciech Mazur's Expert Opinions filed by Bayer Healthcare Pharmaceuticals, Inc., Bayer Schering Pharma AG. (Attachments: #1 Exhibit 1 - Mazur 02-21-17 Report (Blasius), #2 Exhibit 2 - Sealed, #3 Exhibit 3 - Sedlak 2013, #4 Exhibit 4 - Mazur Deposition, #5 Exhibit 5 - Gossett Reports, #6 Exhibit 6 - Mazur 04-06-17 Rebuttal Report (Blasius), #7 Exhibit 7 - Mazur 04-06-17 Rebuttal Report (Evans), #8 Exhibit 8 - Guidance E14, #9 Exhibit 9 - Davis Reports, #10 Exhibit 10 - Whiting Letter, #11 Exhibit 11 - Dinger 2007, #12 Exhibit 12 - PSUR 16 2013, #13 Exhibit 13 - Oct 19 2017 Tregre Letter, #14 Exhibit 14 - Nov 9 2017 Tregre Letter, #15 Exhibit 15 - Mazur CV_Redacted)(Lueckenhoff, Terry) [Transferred from Illinois Southern on 12/11/2018.] |
| Filing 30 MOTION to Exclude - Bayer's Daubert Motion to Exclude Dr. Wojciech Mazur's Expert Opinions by Bayer Healthcare Pharmaceuticals, Inc., Bayer Schering Pharma AG. (Lueckenhoff, Terry) [Transferred from Illinois Southern on 12/11/2018.] |
| Filing 29 Sealed Document. (Attachments: #1 Exhibit 2 - Sealed, #2 Exhibit 3 - Sealed, #3 Exhibit 4 - Sealed, #4 Exhibit 5 - Sealed, #5 Exhibit 7 - Sealed, #6 Exhibit 8 - Sealed, #7 Exhibit 10 - Sealed, #8 Exhibit 12 - Sealed, #9 Exhibit 13 - Sealed, #10 Exhibit 16 - Sealed)(Lueckenhoff, Terry) [Transferred from Illinois Southern on 12/11/2018.] |
| Filing 28 MEMORANDUM in Support re #27 MOTION for Summary Judgment filed by Bayer Healthcare Pharmaceuticals, Inc., Bayer Schering Pharma AG. (Attachments: #1 Exhibit 1 - Sealed, #2 Exhibit 2 - Sealed, #3 Exhibit 3 - Sealed, #4 Exhibit 4 - Sealed, #5 Exhibit 5 - Sealed, #6 Exhibit 6 - Gossett Reports, #7 Exhibit 7 - Sealed, #8 Exhibit 8 - Sealed, #9 Exhibit 9 - Solomon Reports, #10 Exhibit 10 - Sealed, #11 Exhibit 11 - Evans Deposition, #12 Exhibit 12 - Sealed, #13 Exhibit 13 - Sealed, #14 Exhibit 14 - Mazur Deposition, #15 Exhibit 15 - Mazur 02-21-17 Report (Blasius), #16 Exhibit 16 - Sealed, #17 Exhibit 17 - Mazur 04-06-17 Rebuttal Report (Blasius), #18 Exhibit 18 - Mazur 04-06-17 Rebuttal Report (Evans), #19 Exhibit 19 - Sedlak 2013, #20 Exhibit 20 - Guidance E14, #21 Exhibit 21 - Dinger 2007, #22 Exhibit 22 - Yasmin Approval Letter, #23 Exhibit 23 - Gossett Deposition, #24 Exhibit 24 - Eltabbakh Deposition, #25 Exhibit 25 - DelRosario Deposition)(Lueckenhoff, Terry) [Transferred from Illinois Southern on 12/11/2018.] |
| Filing 27 MOTION for Summary Judgment by Bayer Healthcare Pharmaceuticals, Inc., Bayer Schering Pharma AG. Responses due by 1/19/2018 (Lueckenhoff, Terry) [Transferred from Illinois Southern on 12/11/2018.] |
|
Filing 26
ORDER granting #25 Joint Motion to Modify CMO 83 Deadlines. The Court hereby adopts the proposed amended briefing schedule contained in document #25 . Signed by Judge David R. Herndon on 11/13/2017. (ceh)THIS TEXT ENTRY IS AN ORDER OF THE COURT. NO FURTHER DOCUMENTATION WILL BE MAILED. [Transferred from Illinois Southern on 12/11/2018.]
|
| Filing 25 Joint MOTION for Order to - Joint Motion to Modify CMO 83 Deadlines by Bayer Healthcare Pharmaceuticals, Inc.. (Lueckenhoff, Terry) [Transferred from Illinois Southern on 12/11/2018.] |
|
Filing 24
ORDER granting #23 Motion for Order to Modify CMO 83 Deadlines. The Court hereby adopts the scheduling order contained within. Signed by Judge David R. Herndon on 9/5/2017. (ceh) [Transferred from Illinois Southern on 12/11/2018.]
|
| Filing 23 MOTION for Order to - Unopposed Motion to Modify CMO 83 Deadlines by Bayer Healthcare Pharmaceuticals, Inc.. (Lueckenhoff, Terry) [Transferred from Illinois Southern on 12/11/2018.] |
|
Filing 22
ORDER granting #21 Motion for Order to Modify CMO 83 Deadlines. The deadlines contained herein are adopted by the Court extending current due dates for concluding depositions and filing dispositive motions. Signed by Judge David R. Herndon on 7/17/2017. (ceh) [Transferred from Illinois Southern on 12/11/2018.]
|
| Filing 21 Joint MOTION for Order to - Joint Motion to Modify CMO 83 Deadlines by Bayer Healthcare Pharmaceuticals, Inc.. (Lueckenhoff, Terry) [Transferred from Illinois Southern on 12/11/2018.] |
|
Filing 20
ORDER granting #19 Joint Motion to Modify CMO 83 Deadlines. The Court adopts the extended deadlines set forth in the parties' jointly agreed upon stipulation. Signed by Judge David R. Herndon on 5/1/2017. (ceh) [Transferred from Illinois Southern on 12/11/2018.]
|
| Filing 19 Joint MOTION for Order to - Joint Motion to Modify CMO 83 Deadlines by Bayer Healthcare Pharmaceuticals, Inc.. (Lueckenhoff, Terry) [Transferred from Illinois Southern on 12/11/2018.] |
| Filing 18 ANSWER to #2 Complaint, by Barr Laboratories, Inc..(Suffern, Michael) [Transferred from Illinois Southern on 12/11/2018.] |
|
Filing 17
ORDER granting #16 Motion to Amend/Correct. Signed by Judge David R. Herndon on 1/23/2017. (dsw) [Transferred from Illinois Southern on 12/11/2018.]
|
| Filing 16 MOTION to Amend/Correct PLAINTIFFS' UNOPPOSED MOTION TO MODIFY CMO 83 DEADLINES by Carleton Evans, Lisa Evans. (Tregre, Calvin) [Transferred from Illinois Southern on 12/11/2018.] |
|
Filing 15
ORDER Regarding CMO 83 Dispute. Signed by Judge David R. Herndon on 11/23/2016. (Attachments: #1 Exhibit Defense Letter Brief, #2 Exhibit Plaintiff Letter Brief)(dsw) [Transferred from Illinois Southern on 12/11/2018.]
|
| Filing 14 NOTICE of Appearance by David C. Harman on behalf of Carleton Evans, Lisa Evans (Harman, David) [Transferred from Illinois Southern on 12/11/2018.] |
| Filing 13 NOTICE of Appearance by Calvin S. Tregre, Jr on behalf of Carleton Evans, Lisa Evans (Tregre, Calvin) [Transferred from Illinois Southern on 12/11/2018.] |
| Filing 12 NOTICE of Appearance by Janet G. Abaray on behalf of Carleton Evans, Lisa Evans (Abaray, Janet) [Transferred from Illinois Southern on 12/11/2018.] |
| Filing 11 NOTICE of Appearance by Michael J. Suffern on behalf of Teva Pharmaceuticals USA, Inc. (Suffern, Michael) [Transferred from Illinois Southern on 12/11/2018.] |
| Filing 10 ANSWER to #2 Complaint, by Teva Pharmaceuticals USA, Inc..(Hallenbeck, Prentiss) [Transferred from Illinois Southern on 12/11/2018.] |
| Filing 9 NOTICE of Appearance by Prentiss W. Hallenbeck, Jr on behalf of Teva Pharmaceuticals USA, Inc. (Hallenbeck, Prentiss) [Transferred from Illinois Southern on 12/11/2018.] |
|
Filing 8
CASE MANAGEMENT ORDER NUMBER 60, Settlement Agreement and Deadlines - Gallbladder Injuries. Signed by Chief Judge David R. Herndon on 3/15/2013. (Attachments: #1 Exhibit A (Signed Settlement Agreement), #2 Exhibit B (Notice of Intent to Opt Out Form - Appendix B-1), #3 Exhibit C (Notice of Intent to Opt In Form - Appendix B-2), #4 Exhibit D (Declaration - Appendix G))(dsw) [Transferred from Illinois Southern on 12/11/2018.]
|
| Filing 7 ANSWER to #2 Complaint, and Additional Defenses by Bayer Pharma AG, f/k/a Bayer Schering Pharma AG by Bayer Schering Pharma AG.(Lueckenhoff, Terry) [Transferred from Illinois Southern on 12/11/2018.] |
| Filing 6 ANSWER to #2 Complaint, and Additional Defenses by Bayer Healthcare Pharmaceuticals, Inc..(Lueckenhoff, Terry) [Transferred from Illinois Southern on 12/11/2018.] |
| Filing 5 SUMMONS Returned Executed by Carleton Evans, Lisa Evans. Bayer Schering Pharma AG served on 8/23/2011, answer due 9/13/2011. (Kehoe, D.) [Transferred from Illinois Southern on 12/11/2018.] |
| Filing 4 SUMMONS Returned Executed by Carleton Evans, Lisa Evans. Barr Laboratories, Inc. served on 8/3/2011, answer due 8/24/2011; Bayer Healthcare Pharmaceuticals, Inc. served on 8/1/2011, answer due 8/22/2011; Teva Pharmaceuticals USA, Inc. served on 8/1/2011, answer due 8/22/2011. (Kehoe, D.) [Transferred from Illinois Southern on 12/11/2018.] |
| Filing 3 Summons Issued as to Barr Laboratories, Inc., Bayer Healthcare Pharmaceuticals, Inc., Bayer Schering Pharma AG, Teva Pharmaceuticals USA, Inc.. (jlrr ) [Transferred from Illinois Southern on 12/11/2018.] |
| Filing 2 COMPLAINT against Barr Laboratories, Inc., Bayer Healthcare Pharmaceuticals, Inc., Bayer Schering Pharma AG, Teva Pharmaceuticals USA, Inc. ( Filing fee $ 350 receipt number 0754-1160115.), filed by Carleton Evans, Lisa Evans. (Attachments: #1 Civil Cover Sheet)(Kehoe, D.) [Transferred from Illinois Southern on 12/11/2018.] |
| Filing 1 Case Opened. Documents may now be electronically filed. Case number 10-11481-DRH-PMF must be placed on all documents prior to filing them electronically. (drb) [Transferred from Illinois Southern on 12/11/2018.] |
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the Indiana Southern District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
